Table of Contents

June 1, 2018; Volume 59,Issue 6

A

  1. Allaf, Mohamad E.

    1. Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
      Roberto A. Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, Susan C. Harvey, Mehrbod S. Javadi, Lilja B. Solnes, Ana P. Kiess, Mohamad E. Allaf, Martin G. Pomper, Michael A. Gorin and Steven P. Rowe
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 871-877; DOI: https://doi.org/10.2967/jnumed.117.203570

  2. Amir, Tali

    1. Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
      Roberto A. Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, Susan C. Harvey, Mehrbod S. Javadi, Lilja B. Solnes, Ana P. Kiess, Mohamad E. Allaf, Martin G. Pomper, Michael A. Gorin and Steven P. Rowe
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 871-877; DOI: https://doi.org/10.2967/jnumed.117.203570

  3. Andersen, Flemming L.

    1. Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
      Anders Olin, Claes N. Ladefoged, Natasha H. Langer, Sune H. Keller, Johan Löfgren, Adam E. Hansen, Andreas Kjær, Seppo W. Langer, Barbara M. Fischer and Flemming L. Andersen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 999-1004; DOI: https://doi.org/10.2967/jnumed.117.198853

  4. Aoki, Ichio

    1. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
      Ruiqing Ni, Bin Ji, Maiko Ono, Naruhiko Sahara, Ming-Rong Zhang, Ichio Aoki, Agneta Nordberg, Tetsuya Suhara and Makoto Higuchi
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 960-966; DOI: https://doi.org/10.2967/jnumed.117.201632

B

  1. Badawi, Ramsey D.

    1. Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging
      Eric Berg, Xuezhu Zhang, Julien Bec, Martin S. Judenhofer, Brijesh Patel, Qiyu Peng, Maciej Kapusta, Matthias Schmand, Michael E. Casey, Alice F. Tarantal, Jinyi Qi, Ramsey D. Badawi and Simon R. Cherry
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 993-998; DOI: https://doi.org/10.2967/jnumed.117.200519

  2. Bauman, Andreas

    1. Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
      Guillaume P. Nicolas, Seval Beykan, Hakim Bouterfa, Jens Kaufmann, Andreas Bauman, Michael Lassmann, Jean Claude Reubi, Jean E.F. Rivier, Helmut R. Maecke, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 909-914; DOI: https://doi.org/10.2967/jnumed.117.199737

  3. Bec, Julien

    1. Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging
      Eric Berg, Xuezhu Zhang, Julien Bec, Martin S. Judenhofer, Brijesh Patel, Qiyu Peng, Maciej Kapusta, Matthias Schmand, Michael E. Casey, Alice F. Tarantal, Jinyi Qi, Ramsey D. Badawi and Simon R. Cherry
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 993-998; DOI: https://doi.org/10.2967/jnumed.117.200519

  4. Beer, Ambros J.

    1. The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177Lu-Labeled PSMA Peptides
      Nusrat J. Begum, Anne Thieme, Nina Eberhardt, Robert Tauber, Calogero D’Alessandria, Ambros J. Beer, Gerhard Glatting, Matthias Eiber and Peter Kletting
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 929-933; DOI: https://doi.org/10.2967/jnumed.117.203505

  5. Begum, Nusrat J.

    1. The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177Lu-Labeled PSMA Peptides
      Nusrat J. Begum, Anne Thieme, Nina Eberhardt, Robert Tauber, Calogero D’Alessandria, Ambros J. Beer, Gerhard Glatting, Matthias Eiber and Peter Kletting
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 929-933; DOI: https://doi.org/10.2967/jnumed.117.203505

  6. Beijnen, Jos H.

    1. Molecular Imaging of ABCB1 and ABCG2 Inhibition at the Human Blood–Brain Barrier Using Elacridar and 11C-Erlotinib PET
      Remy B. Verheijen, Maqsood Yaqub, Emilia Sawicki, Olaf van Tellingen, Adriaan A. Lammertsma, Bastiaan Nuijen, Jan H.M. Schellens, Jos H. Beijnen, Alwin D.R. Huitema, N. Harry Hendrikse and Neeltje Steeghs
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 973-979; DOI: https://doi.org/10.2967/jnumed.117.195800

  7. Berg, Eric

    1. Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging
      Eric Berg, Xuezhu Zhang, Julien Bec, Martin S. Judenhofer, Brijesh Patel, Qiyu Peng, Maciej Kapusta, Matthias Schmand, Michael E. Casey, Alice F. Tarantal, Jinyi Qi, Ramsey D. Badawi and Simon R. Cherry
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 993-998; DOI: https://doi.org/10.2967/jnumed.117.200519

  8. Beyer, Thomas

    1. Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
      László Papp, Nina Pötsch, Marko Grahovac, Victor Schmidbauer, Adelheid Woehrer, Matthias Preusser, Markus Mitterhauser, Barbara Kiesel, Wolfgang Wadsak, Thomas Beyer, Marcus Hacker and Tatjana Traub-Weidinger
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 892-899; DOI: https://doi.org/10.2967/jnumed.117.202267

  9. Beykan, Seval

    1. Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
      Guillaume P. Nicolas, Seval Beykan, Hakim Bouterfa, Jens Kaufmann, Andreas Bauman, Michael Lassmann, Jean Claude Reubi, Jean E.F. Rivier, Helmut R. Maecke, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 909-914; DOI: https://doi.org/10.2967/jnumed.117.199737

  10. Biswal, Sandip

    1. 18F-FDG PET/MRI in Chronic Sciatica: Early Results Revealing Spinal and Nonspinal Abnormalities
      Peter W. Cipriano, Daehyun Yoon, Harsh Gandhi, Dawn Holley, Dushyant Thakur, Brian A. Hargreaves, David J. Kennedy, Matthew W. Smuck, Ivan Cheng and Sandip Biswal
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 967-972; DOI: https://doi.org/10.2967/jnumed.117.198259

  11. Bodei, Lisa

    1. Somatostatin Receptor Imaging of Neuroendocrine Tumors: From Agonists to Antagonists
      Lisa Bodei and Wolfgang A. Weber
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 907-908; DOI: https://doi.org/10.2967/jnumed.117.205161

  12. Bormans, Guy

    1. Glutamatergic Biomarkers for Cocaine Addiction: A Longitudinal Study Using MR Spectroscopy and mGluR5 PET in Self-Administering Rats
      Bart de Laat, Akila Weerasekera, Gil Leurquin-Sterk, Guy Bormans, Uwe Himmelreich, Cindy Casteels and Koen Van Laere
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 952-959; DOI: https://doi.org/10.2967/jnumed.117.202614

  13. Bouterfa, Hakim

    1. Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
      Guillaume P. Nicolas, Seval Beykan, Hakim Bouterfa, Jens Kaufmann, Andreas Bauman, Michael Lassmann, Jean Claude Reubi, Jean E.F. Rivier, Helmut R. Maecke, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 909-914; DOI: https://doi.org/10.2967/jnumed.117.199737
    2. Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
      Guillaume P. Nicolas, Nils Schreiter, Felix Kaul, John Uiters, Hakim Bouterfa, Jens Kaufmann, Tobias E. Erlanger, Richard Cathomas, Emanuel Christ, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 915-921; DOI: https://doi.org/10.2967/jnumed.117.199760

  14. Braun, Jonathan

    1. Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis
      Amanda C. Freise, Kirstin A. Zettlitz, Felix B. Salazar, Richard Tavaré, Wen-Ting K. Tsai, Arion F. Chatziioannou, Nora Rozengurt, Jonathan Braun and Anna M. Wu
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 980-985; DOI: https://doi.org/10.2967/jnumed.117.199075

  15. Buckle, Tessa

    1. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer
      Tessa Buckle, Danny M. van Willigen, Silvia J. Spa, Albertus W. Hensbergen, Steffen van der Wal, Clarize M. de Korne, Mick M. Welling, Henk G. van der Poel, James C.H. Hardwick and Fijs W.B. van Leeuwen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 986-992; DOI: https://doi.org/10.2967/jnumed.117.205575

C

  1. Canaria, Christie A.

    1. Proceedings of the NCI SBIR Workshop on Molecularly Targeted Radionuclide Therapy
      Christie A. Canaria, M. Lisa Yeom, Jacek Capala and Deepa Narayanan
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 13N-14N;

  2. Capala, Jacek

    1. Proceedings of the NCI SBIR Workshop on Molecularly Targeted Radionuclide Therapy
      Christie A. Canaria, M. Lisa Yeom, Jacek Capala and Deepa Narayanan
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 13N-14N;

  3. Carlin, Sean

    1. Penetrating the Barriers to Successful α-Radioimmunotherapy
      Sean Carlin
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 934-936; DOI: https://doi.org/10.2967/jnumed.117.205146

  4. Casey, Michael E.

    1. Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging
      Eric Berg, Xuezhu Zhang, Julien Bec, Martin S. Judenhofer, Brijesh Patel, Qiyu Peng, Maciej Kapusta, Matthias Schmand, Michael E. Casey, Alice F. Tarantal, Jinyi Qi, Ramsey D. Badawi and Simon R. Cherry
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 993-998; DOI: https://doi.org/10.2967/jnumed.117.200519

  5. Casteels, Cindy

    1. Glutamatergic Biomarkers for Cocaine Addiction: A Longitudinal Study Using MR Spectroscopy and mGluR5 PET in Self-Administering Rats
      Bart de Laat, Akila Weerasekera, Gil Leurquin-Sterk, Guy Bormans, Uwe Himmelreich, Cindy Casteels and Koen Van Laere
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 952-959; DOI: https://doi.org/10.2967/jnumed.117.202614

  6. Cathomas, Richard

    1. Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
      Guillaume P. Nicolas, Nils Schreiter, Felix Kaul, John Uiters, Hakim Bouterfa, Jens Kaufmann, Tobias E. Erlanger, Richard Cathomas, Emanuel Christ, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 915-921; DOI: https://doi.org/10.2967/jnumed.117.199760

  7. Chatziioannou, Arion F.

    1. Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis
      Amanda C. Freise, Kirstin A. Zettlitz, Felix B. Salazar, Richard Tavaré, Wen-Ting K. Tsai, Arion F. Chatziioannou, Nora Rozengurt, Jonathan Braun and Anna M. Wu
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 980-985; DOI: https://doi.org/10.2967/jnumed.117.199075

  8. Chen, Libo

    1. PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients
      Jingjing Zhang, Gang Niu, Xinrong Fan, Lixin Lang, Guozhu Hou, Libo Chen, Huanwen Wu, Zhaohui Zhu, Fang Li and Xiaoyuan Chen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 922-928; DOI: https://doi.org/10.2967/jnumed.117.198929

  9. Chen, Xiaoyuan

    1. PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients
      Jingjing Zhang, Gang Niu, Xinrong Fan, Lixin Lang, Guozhu Hou, Libo Chen, Huanwen Wu, Zhaohui Zhu, Fang Li and Xiaoyuan Chen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 922-928; DOI: https://doi.org/10.2967/jnumed.117.198929

  10. Cheng, Ivan

    1. 18F-FDG PET/MRI in Chronic Sciatica: Early Results Revealing Spinal and Nonspinal Abnormalities
      Peter W. Cipriano, Daehyun Yoon, Harsh Gandhi, Dawn Holley, Dushyant Thakur, Brian A. Hargreaves, David J. Kennedy, Matthew W. Smuck, Ivan Cheng and Sandip Biswal
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 967-972; DOI: https://doi.org/10.2967/jnumed.117.198259

  11. Cherry, Simon R.

    1. Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging
      Eric Berg, Xuezhu Zhang, Julien Bec, Martin S. Judenhofer, Brijesh Patel, Qiyu Peng, Maciej Kapusta, Matthias Schmand, Michael E. Casey, Alice F. Tarantal, Jinyi Qi, Ramsey D. Badawi and Simon R. Cherry
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 993-998; DOI: https://doi.org/10.2967/jnumed.117.200519

  12. Christ, Emanuel

    1. Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
      Guillaume P. Nicolas, Nils Schreiter, Felix Kaul, John Uiters, Hakim Bouterfa, Jens Kaufmann, Tobias E. Erlanger, Richard Cathomas, Emanuel Christ, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 915-921; DOI: https://doi.org/10.2967/jnumed.117.199760

  13. Cipriano, Peter W.

    1. 18F-FDG PET/MRI in Chronic Sciatica: Early Results Revealing Spinal and Nonspinal Abnormalities
      Peter W. Cipriano, Daehyun Yoon, Harsh Gandhi, Dawn Holley, Dushyant Thakur, Brian A. Hargreaves, David J. Kennedy, Matthew W. Smuck, Ivan Cheng and Sandip Biswal
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 967-972; DOI: https://doi.org/10.2967/jnumed.117.198259

  14. Clarke, Bonnie

    1. Perspective on How the FDA Should Review Diagnostic Radiopharmaceuticals
      Sally W. Schwarz and Bonnie Clarke
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 865-867; DOI: https://doi.org/10.2967/jnumed.117.204446

D

  1. D’Alessandria, Calogero

    1. The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177Lu-Labeled PSMA Peptides
      Nusrat J. Begum, Anne Thieme, Nina Eberhardt, Robert Tauber, Calogero D’Alessandria, Ambros J. Beer, Gerhard Glatting, Matthias Eiber and Peter Kletting
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 929-933; DOI: https://doi.org/10.2967/jnumed.117.203505

  2. D’Huyvetter, Matthias

    1. Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology
      Ahmet Krasniqi, Matthias D’Huyvetter, Nick Devoogdt, Fredrik Y. Frejd, Jens Sörensen, Anna Orlova, Marleen Keyaerts and Vladimir Tolmachev
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 885-891; DOI: https://doi.org/10.2967/jnumed.117.199901

  3. de Korne, Clarize M.

    1. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer
      Tessa Buckle, Danny M. van Willigen, Silvia J. Spa, Albertus W. Hensbergen, Steffen van der Wal, Clarize M. de Korne, Mick M. Welling, Henk G. van der Poel, James C.H. Hardwick and Fijs W.B. van Leeuwen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 986-992; DOI: https://doi.org/10.2967/jnumed.117.205575

  4. de Laat, Bart

    1. Glutamatergic Biomarkers for Cocaine Addiction: A Longitudinal Study Using MR Spectroscopy and mGluR5 PET in Self-Administering Rats
      Bart de Laat, Akila Weerasekera, Gil Leurquin-Sterk, Guy Bormans, Uwe Himmelreich, Cindy Casteels and Koen Van Laere
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 952-959; DOI: https://doi.org/10.2967/jnumed.117.202614

  5. Devoogdt, Nick

    1. Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology
      Ahmet Krasniqi, Matthias D’Huyvetter, Nick Devoogdt, Fredrik Y. Frejd, Jens Sörensen, Anna Orlova, Marleen Keyaerts and Vladimir Tolmachev
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 885-891; DOI: https://doi.org/10.2967/jnumed.117.199901

  6. Devous, Michael D.

    1. Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity
      Sudeepti Southekal, Michael D. Devous, Ian Kennedy, Michael Navitsky, Ming Lu, Abhinay D. Joshi, Michael J. Pontecorvo and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 944-951; DOI: https://doi.org/10.2967/jnumed.117.200006
    2. Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
      Michael D. Devous, Abhinay D. Joshi, Michael Navitsky, Sudeepti Southekal, Michael J. Pontecorvo, Haiqing Shen, Ming Lu, William R. Shankle, John P. Seibyl, Ken Marek and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 937-943; DOI: https://doi.org/10.2967/jnumed.117.200691

E

  1. Eberhardt, Nina

    1. The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177Lu-Labeled PSMA Peptides
      Nusrat J. Begum, Anne Thieme, Nina Eberhardt, Robert Tauber, Calogero D’Alessandria, Ambros J. Beer, Gerhard Glatting, Matthias Eiber and Peter Kletting
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 929-933; DOI: https://doi.org/10.2967/jnumed.117.203505

  2. Eiber, Matthias

    1. The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177Lu-Labeled PSMA Peptides
      Nusrat J. Begum, Anne Thieme, Nina Eberhardt, Robert Tauber, Calogero D’Alessandria, Ambros J. Beer, Gerhard Glatting, Matthias Eiber and Peter Kletting
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 929-933; DOI: https://doi.org/10.2967/jnumed.117.203505

  3. Erlanger, Tobias E.

    1. Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
      Guillaume P. Nicolas, Nils Schreiter, Felix Kaul, John Uiters, Hakim Bouterfa, Jens Kaufmann, Tobias E. Erlanger, Richard Cathomas, Emanuel Christ, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 915-921; DOI: https://doi.org/10.2967/jnumed.117.199760

F

  1. Fan, Xinrong

    1. PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients
      Jingjing Zhang, Gang Niu, Xinrong Fan, Lixin Lang, Guozhu Hou, Libo Chen, Huanwen Wu, Zhaohui Zhu, Fang Li and Xiaoyuan Chen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 922-928; DOI: https://doi.org/10.2967/jnumed.117.198929

  2. Fani, Melpomeni

    1. Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
      Guillaume P. Nicolas, Seval Beykan, Hakim Bouterfa, Jens Kaufmann, Andreas Bauman, Michael Lassmann, Jean Claude Reubi, Jean E.F. Rivier, Helmut R. Maecke, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 909-914; DOI: https://doi.org/10.2967/jnumed.117.199737
    2. Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
      Guillaume P. Nicolas, Nils Schreiter, Felix Kaul, John Uiters, Hakim Bouterfa, Jens Kaufmann, Tobias E. Erlanger, Richard Cathomas, Emanuel Christ, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 915-921; DOI: https://doi.org/10.2967/jnumed.117.199760

  3. Fischer, Barbara M.

    1. Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
      Anders Olin, Claes N. Ladefoged, Natasha H. Langer, Sune H. Keller, Johan Löfgren, Adam E. Hansen, Andreas Kjær, Seppo W. Langer, Barbara M. Fischer and Flemming L. Andersen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 999-1004; DOI: https://doi.org/10.2967/jnumed.117.198853

  4. Francesconi, Lynn C.

    1. α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1
      Sophie Poty, Lynn C. Francesconi, Michael R. McDevitt, Michael J. Morris and Jason S. Lewis
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 878-884; DOI: https://doi.org/10.2967/jnumed.116.186338

  5. Freise, Amanda C.

    1. Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis
      Amanda C. Freise, Kirstin A. Zettlitz, Felix B. Salazar, Richard Tavaré, Wen-Ting K. Tsai, Arion F. Chatziioannou, Nora Rozengurt, Jonathan Braun and Anna M. Wu
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 980-985; DOI: https://doi.org/10.2967/jnumed.117.199075

  6. Frejd, Fredrik Y.

    1. Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology
      Ahmet Krasniqi, Matthias D’Huyvetter, Nick Devoogdt, Fredrik Y. Frejd, Jens Sörensen, Anna Orlova, Marleen Keyaerts and Vladimir Tolmachev
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 885-891; DOI: https://doi.org/10.2967/jnumed.117.199901

G

  1. Gandhi, Harsh

    1. 18F-FDG PET/MRI in Chronic Sciatica: Early Results Revealing Spinal and Nonspinal Abnormalities
      Peter W. Cipriano, Daehyun Yoon, Harsh Gandhi, Dawn Holley, Dushyant Thakur, Brian A. Hargreaves, David J. Kennedy, Matthew W. Smuck, Ivan Cheng and Sandip Biswal
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 967-972; DOI: https://doi.org/10.2967/jnumed.117.198259

  2. Glatting, Gerhard

    1. The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177Lu-Labeled PSMA Peptides
      Nusrat J. Begum, Anne Thieme, Nina Eberhardt, Robert Tauber, Calogero D’Alessandria, Ambros J. Beer, Gerhard Glatting, Matthias Eiber and Peter Kletting
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 929-933; DOI: https://doi.org/10.2967/jnumed.117.203505

  3. Gorin, Michael A.

    1. Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
      Roberto A. Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, Susan C. Harvey, Mehrbod S. Javadi, Lilja B. Solnes, Ana P. Kiess, Mohamad E. Allaf, Martin G. Pomper, Michael A. Gorin and Steven P. Rowe
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 871-877; DOI: https://doi.org/10.2967/jnumed.117.203570

  4. Grahovac, Marko

    1. Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
      László Papp, Nina Pötsch, Marko Grahovac, Victor Schmidbauer, Adelheid Woehrer, Matthias Preusser, Markus Mitterhauser, Barbara Kiesel, Wolfgang Wadsak, Thomas Beyer, Marcus Hacker and Tatjana Traub-Weidinger
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 892-899; DOI: https://doi.org/10.2967/jnumed.117.202267

  5. Greenspan, Bennett S.

    1. SNMMI Leadership Update: Implementing the Value Initiative
      Bennett S. Greenspan
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 17N-18N;

  6. Groheux, David

    1. Now Is the Time to Use 18F-FDG PET/CT to Optimize Neoadjuvant Treatment in Triple-Negative Breast Cancer!
      David Groheux
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 863-864; DOI: https://doi.org/10.2967/jnumed.118.210922

H

  1. Hacker, Marcus

    1. Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
      László Papp, Nina Pötsch, Marko Grahovac, Victor Schmidbauer, Adelheid Woehrer, Matthias Preusser, Markus Mitterhauser, Barbara Kiesel, Wolfgang Wadsak, Thomas Beyer, Marcus Hacker and Tatjana Traub-Weidinger
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 892-899; DOI: https://doi.org/10.2967/jnumed.117.202267

  2. Hansen, Adam E.

    1. Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
      Anders Olin, Claes N. Ladefoged, Natasha H. Langer, Sune H. Keller, Johan Löfgren, Adam E. Hansen, Andreas Kjær, Seppo W. Langer, Barbara M. Fischer and Flemming L. Andersen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 999-1004; DOI: https://doi.org/10.2967/jnumed.117.198853

  3. Hardwick, James C.H.

    1. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer
      Tessa Buckle, Danny M. van Willigen, Silvia J. Spa, Albertus W. Hensbergen, Steffen van der Wal, Clarize M. de Korne, Mick M. Welling, Henk G. van der Poel, James C.H. Hardwick and Fijs W.B. van Leeuwen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 986-992; DOI: https://doi.org/10.2967/jnumed.117.205575

  4. Hargreaves, Brian A.

    1. 18F-FDG PET/MRI in Chronic Sciatica: Early Results Revealing Spinal and Nonspinal Abnormalities
      Peter W. Cipriano, Daehyun Yoon, Harsh Gandhi, Dawn Holley, Dushyant Thakur, Brian A. Hargreaves, David J. Kennedy, Matthew W. Smuck, Ivan Cheng and Sandip Biswal
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 967-972; DOI: https://doi.org/10.2967/jnumed.117.198259

  5. Harvey, Susan C.

    1. Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
      Roberto A. Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, Susan C. Harvey, Mehrbod S. Javadi, Lilja B. Solnes, Ana P. Kiess, Mohamad E. Allaf, Martin G. Pomper, Michael A. Gorin and Steven P. Rowe
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 871-877; DOI: https://doi.org/10.2967/jnumed.117.203570

  6. Hendrikse, N. Harry

    1. Molecular Imaging of ABCB1 and ABCG2 Inhibition at the Human Blood–Brain Barrier Using Elacridar and 11C-Erlotinib PET
      Remy B. Verheijen, Maqsood Yaqub, Emilia Sawicki, Olaf van Tellingen, Adriaan A. Lammertsma, Bastiaan Nuijen, Jan H.M. Schellens, Jos H. Beijnen, Alwin D.R. Huitema, N. Harry Hendrikse and Neeltje Steeghs
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 973-979; DOI: https://doi.org/10.2967/jnumed.117.195800

  7. Hensbergen, Albertus W.

    1. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer
      Tessa Buckle, Danny M. van Willigen, Silvia J. Spa, Albertus W. Hensbergen, Steffen van der Wal, Clarize M. de Korne, Mick M. Welling, Henk G. van der Poel, James C.H. Hardwick and Fijs W.B. van Leeuwen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 986-992; DOI: https://doi.org/10.2967/jnumed.117.205575

  8. Higuchi, Makoto

    1. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
      Ruiqing Ni, Bin Ji, Maiko Ono, Naruhiko Sahara, Ming-Rong Zhang, Ichio Aoki, Agneta Nordberg, Tetsuya Suhara and Makoto Higuchi
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 960-966; DOI: https://doi.org/10.2967/jnumed.117.201632

  9. Himmelreich, Uwe

    1. Glutamatergic Biomarkers for Cocaine Addiction: A Longitudinal Study Using MR Spectroscopy and mGluR5 PET in Self-Administering Rats
      Bart de Laat, Akila Weerasekera, Gil Leurquin-Sterk, Guy Bormans, Uwe Himmelreich, Cindy Casteels and Koen Van Laere
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 952-959; DOI: https://doi.org/10.2967/jnumed.117.202614

  10. Holley, Dawn

    1. 18F-FDG PET/MRI in Chronic Sciatica: Early Results Revealing Spinal and Nonspinal Abnormalities
      Peter W. Cipriano, Daehyun Yoon, Harsh Gandhi, Dawn Holley, Dushyant Thakur, Brian A. Hargreaves, David J. Kennedy, Matthew W. Smuck, Ivan Cheng and Sandip Biswal
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 967-972; DOI: https://doi.org/10.2967/jnumed.117.198259

  11. Hou, Guozhu

    1. PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients
      Jingjing Zhang, Gang Niu, Xinrong Fan, Lixin Lang, Guozhu Hou, Libo Chen, Huanwen Wu, Zhaohui Zhu, Fang Li and Xiaoyuan Chen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 922-928; DOI: https://doi.org/10.2967/jnumed.117.198929

  12. Huitema, Alwin D.R.

    1. Molecular Imaging of ABCB1 and ABCG2 Inhibition at the Human Blood–Brain Barrier Using Elacridar and 11C-Erlotinib PET
      Remy B. Verheijen, Maqsood Yaqub, Emilia Sawicki, Olaf van Tellingen, Adriaan A. Lammertsma, Bastiaan Nuijen, Jan H.M. Schellens, Jos H. Beijnen, Alwin D.R. Huitema, N. Harry Hendrikse and Neeltje Steeghs
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 973-979; DOI: https://doi.org/10.2967/jnumed.117.195800

J

  1. Javadi, Mehrbod S.

    1. Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
      Roberto A. Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, Susan C. Harvey, Mehrbod S. Javadi, Lilja B. Solnes, Ana P. Kiess, Mohamad E. Allaf, Martin G. Pomper, Michael A. Gorin and Steven P. Rowe
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 871-877; DOI: https://doi.org/10.2967/jnumed.117.203570

  2. Jhaveri, Komal

    1. First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
      Gary A. Ulaner, Serge K. Lyashchenko, Christopher Riedl, Shutian Ruan, Pat B. Zanzonico, Diana Lake, Komal Jhaveri, Brian Zeglis, Jason S. Lewis and Joseph A. O’Donoghue
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 900-906; DOI: https://doi.org/10.2967/jnumed.117.202010

  3. Ji, Bin

    1. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
      Ruiqing Ni, Bin Ji, Maiko Ono, Naruhiko Sahara, Ming-Rong Zhang, Ichio Aoki, Agneta Nordberg, Tetsuya Suhara and Makoto Higuchi
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 960-966; DOI: https://doi.org/10.2967/jnumed.117.201632

  4. Joshi, Abhinay D.

    1. Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity
      Sudeepti Southekal, Michael D. Devous, Ian Kennedy, Michael Navitsky, Ming Lu, Abhinay D. Joshi, Michael J. Pontecorvo and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 944-951; DOI: https://doi.org/10.2967/jnumed.117.200006
    2. Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
      Michael D. Devous, Abhinay D. Joshi, Michael Navitsky, Sudeepti Southekal, Michael J. Pontecorvo, Haiqing Shen, Ming Lu, William R. Shankle, John P. Seibyl, Ken Marek and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 937-943; DOI: https://doi.org/10.2967/jnumed.117.200691

  5. Judenhofer, Martin S.

    1. Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging
      Eric Berg, Xuezhu Zhang, Julien Bec, Martin S. Judenhofer, Brijesh Patel, Qiyu Peng, Maciej Kapusta, Matthias Schmand, Michael E. Casey, Alice F. Tarantal, Jinyi Qi, Ramsey D. Badawi and Simon R. Cherry
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 993-998; DOI: https://doi.org/10.2967/jnumed.117.200519

K

  1. Kapusta, Maciej

    1. Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging
      Eric Berg, Xuezhu Zhang, Julien Bec, Martin S. Judenhofer, Brijesh Patel, Qiyu Peng, Maciej Kapusta, Matthias Schmand, Michael E. Casey, Alice F. Tarantal, Jinyi Qi, Ramsey D. Badawi and Simon R. Cherry
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 993-998; DOI: https://doi.org/10.2967/jnumed.117.200519

  2. Kaufmann, Jens

    1. Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
      Guillaume P. Nicolas, Seval Beykan, Hakim Bouterfa, Jens Kaufmann, Andreas Bauman, Michael Lassmann, Jean Claude Reubi, Jean E.F. Rivier, Helmut R. Maecke, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 909-914; DOI: https://doi.org/10.2967/jnumed.117.199737
    2. Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
      Guillaume P. Nicolas, Nils Schreiter, Felix Kaul, John Uiters, Hakim Bouterfa, Jens Kaufmann, Tobias E. Erlanger, Richard Cathomas, Emanuel Christ, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 915-921; DOI: https://doi.org/10.2967/jnumed.117.199760

  3. Kaul, Felix

    1. Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
      Guillaume P. Nicolas, Nils Schreiter, Felix Kaul, John Uiters, Hakim Bouterfa, Jens Kaufmann, Tobias E. Erlanger, Richard Cathomas, Emanuel Christ, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 915-921; DOI: https://doi.org/10.2967/jnumed.117.199760

  4. Keller, Sune H.

    1. Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
      Anders Olin, Claes N. Ladefoged, Natasha H. Langer, Sune H. Keller, Johan Löfgren, Adam E. Hansen, Andreas Kjær, Seppo W. Langer, Barbara M. Fischer and Flemming L. Andersen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 999-1004; DOI: https://doi.org/10.2967/jnumed.117.198853

  5. Kennedy, David J.

    1. 18F-FDG PET/MRI in Chronic Sciatica: Early Results Revealing Spinal and Nonspinal Abnormalities
      Peter W. Cipriano, Daehyun Yoon, Harsh Gandhi, Dawn Holley, Dushyant Thakur, Brian A. Hargreaves, David J. Kennedy, Matthew W. Smuck, Ivan Cheng and Sandip Biswal
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 967-972; DOI: https://doi.org/10.2967/jnumed.117.198259

  6. Kennedy, Ian

    1. Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity
      Sudeepti Southekal, Michael D. Devous, Ian Kennedy, Michael Navitsky, Ming Lu, Abhinay D. Joshi, Michael J. Pontecorvo and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 944-951; DOI: https://doi.org/10.2967/jnumed.117.200006

  7. Keyaerts, Marleen

    1. Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology
      Ahmet Krasniqi, Matthias D’Huyvetter, Nick Devoogdt, Fredrik Y. Frejd, Jens Sörensen, Anna Orlova, Marleen Keyaerts and Vladimir Tolmachev
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 885-891; DOI: https://doi.org/10.2967/jnumed.117.199901

  8. Kiesel, Barbara

    1. Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
      László Papp, Nina Pötsch, Marko Grahovac, Victor Schmidbauer, Adelheid Woehrer, Matthias Preusser, Markus Mitterhauser, Barbara Kiesel, Wolfgang Wadsak, Thomas Beyer, Marcus Hacker and Tatjana Traub-Weidinger
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 892-899; DOI: https://doi.org/10.2967/jnumed.117.202267

  9. Kiess, Ana P.

    1. Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
      Roberto A. Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, Susan C. Harvey, Mehrbod S. Javadi, Lilja B. Solnes, Ana P. Kiess, Mohamad E. Allaf, Martin G. Pomper, Michael A. Gorin and Steven P. Rowe
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 871-877; DOI: https://doi.org/10.2967/jnumed.117.203570

  10. Kjær, Andreas

    1. Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
      Anders Olin, Claes N. Ladefoged, Natasha H. Langer, Sune H. Keller, Johan Löfgren, Adam E. Hansen, Andreas Kjær, Seppo W. Langer, Barbara M. Fischer and Flemming L. Andersen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 999-1004; DOI: https://doi.org/10.2967/jnumed.117.198853

  11. Kletting, Peter

    1. The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177Lu-Labeled PSMA Peptides
      Nusrat J. Begum, Anne Thieme, Nina Eberhardt, Robert Tauber, Calogero D’Alessandria, Ambros J. Beer, Gerhard Glatting, Matthias Eiber and Peter Kletting
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 929-933; DOI: https://doi.org/10.2967/jnumed.117.203505

  12. Krasniqi, Ahmet

    1. Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology
      Ahmet Krasniqi, Matthias D’Huyvetter, Nick Devoogdt, Fredrik Y. Frejd, Jens Sörensen, Anna Orlova, Marleen Keyaerts and Vladimir Tolmachev
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 885-891; DOI: https://doi.org/10.2967/jnumed.117.199901

L

  1. Ladefoged, Claes N.

    1. Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
      Anders Olin, Claes N. Ladefoged, Natasha H. Langer, Sune H. Keller, Johan Löfgren, Adam E. Hansen, Andreas Kjær, Seppo W. Langer, Barbara M. Fischer and Flemming L. Andersen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 999-1004; DOI: https://doi.org/10.2967/jnumed.117.198853

  2. Lake, Diana

    1. First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
      Gary A. Ulaner, Serge K. Lyashchenko, Christopher Riedl, Shutian Ruan, Pat B. Zanzonico, Diana Lake, Komal Jhaveri, Brian Zeglis, Jason S. Lewis and Joseph A. O’Donoghue
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 900-906; DOI: https://doi.org/10.2967/jnumed.117.202010

  3. Lammertsma, Adriaan A.

    1. Molecular Imaging of ABCB1 and ABCG2 Inhibition at the Human Blood–Brain Barrier Using Elacridar and 11C-Erlotinib PET
      Remy B. Verheijen, Maqsood Yaqub, Emilia Sawicki, Olaf van Tellingen, Adriaan A. Lammertsma, Bastiaan Nuijen, Jan H.M. Schellens, Jos H. Beijnen, Alwin D.R. Huitema, N. Harry Hendrikse and Neeltje Steeghs
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 973-979; DOI: https://doi.org/10.2967/jnumed.117.195800

  4. Lang, Lixin

    1. PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients
      Jingjing Zhang, Gang Niu, Xinrong Fan, Lixin Lang, Guozhu Hou, Libo Chen, Huanwen Wu, Zhaohui Zhu, Fang Li and Xiaoyuan Chen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 922-928; DOI: https://doi.org/10.2967/jnumed.117.198929

  5. Langer, Natasha H.

    1. Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
      Anders Olin, Claes N. Ladefoged, Natasha H. Langer, Sune H. Keller, Johan Löfgren, Adam E. Hansen, Andreas Kjær, Seppo W. Langer, Barbara M. Fischer and Flemming L. Andersen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 999-1004; DOI: https://doi.org/10.2967/jnumed.117.198853

  6. Langer, Seppo W.

    1. Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
      Anders Olin, Claes N. Ladefoged, Natasha H. Langer, Sune H. Keller, Johan Löfgren, Adam E. Hansen, Andreas Kjær, Seppo W. Langer, Barbara M. Fischer and Flemming L. Andersen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 999-1004; DOI: https://doi.org/10.2967/jnumed.117.198853

  7. Lassmann, Michael

    1. Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
      Guillaume P. Nicolas, Seval Beykan, Hakim Bouterfa, Jens Kaufmann, Andreas Bauman, Michael Lassmann, Jean Claude Reubi, Jean E.F. Rivier, Helmut R. Maecke, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 909-914; DOI: https://doi.org/10.2967/jnumed.117.199737

  8. Leurquin-Sterk, Gil

    1. Glutamatergic Biomarkers for Cocaine Addiction: A Longitudinal Study Using MR Spectroscopy and mGluR5 PET in Self-Administering Rats
      Bart de Laat, Akila Weerasekera, Gil Leurquin-Sterk, Guy Bormans, Uwe Himmelreich, Cindy Casteels and Koen Van Laere
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 952-959; DOI: https://doi.org/10.2967/jnumed.117.202614

  9. Lewis, Jason S.

    1. α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1
      Sophie Poty, Lynn C. Francesconi, Michael R. McDevitt, Michael J. Morris and Jason S. Lewis
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 878-884; DOI: https://doi.org/10.2967/jnumed.116.186338
    2. First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
      Gary A. Ulaner, Serge K. Lyashchenko, Christopher Riedl, Shutian Ruan, Pat B. Zanzonico, Diana Lake, Komal Jhaveri, Brian Zeglis, Jason S. Lewis and Joseph A. O’Donoghue
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 900-906; DOI: https://doi.org/10.2967/jnumed.117.202010

  10. Li, Fang

    1. PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients
      Jingjing Zhang, Gang Niu, Xinrong Fan, Lixin Lang, Guozhu Hou, Libo Chen, Huanwen Wu, Zhaohui Zhu, Fang Li and Xiaoyuan Chen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 922-928; DOI: https://doi.org/10.2967/jnumed.117.198929

  11. Lisa Yeom, M.

    1. Proceedings of the NCI SBIR Workshop on Molecularly Targeted Radionuclide Therapy
      Christie A. Canaria, M. Lisa Yeom, Jacek Capala and Deepa Narayanan
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 13N-14N;

  12. Löfgren, Johan

    1. Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
      Anders Olin, Claes N. Ladefoged, Natasha H. Langer, Sune H. Keller, Johan Löfgren, Adam E. Hansen, Andreas Kjær, Seppo W. Langer, Barbara M. Fischer and Flemming L. Andersen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 999-1004; DOI: https://doi.org/10.2967/jnumed.117.198853

  13. Lu, Ming

    1. Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity
      Sudeepti Southekal, Michael D. Devous, Ian Kennedy, Michael Navitsky, Ming Lu, Abhinay D. Joshi, Michael J. Pontecorvo and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 944-951; DOI: https://doi.org/10.2967/jnumed.117.200006
    2. Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
      Michael D. Devous, Abhinay D. Joshi, Michael Navitsky, Sudeepti Southekal, Michael J. Pontecorvo, Haiqing Shen, Ming Lu, William R. Shankle, John P. Seibyl, Ken Marek and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 937-943; DOI: https://doi.org/10.2967/jnumed.117.200691

  14. Lyashchenko, Serge K.

    1. First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
      Gary A. Ulaner, Serge K. Lyashchenko, Christopher Riedl, Shutian Ruan, Pat B. Zanzonico, Diana Lake, Komal Jhaveri, Brian Zeglis, Jason S. Lewis and Joseph A. O’Donoghue
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 900-906; DOI: https://doi.org/10.2967/jnumed.117.202010

M

  1. Maecke, Helmut R.

    1. Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
      Guillaume P. Nicolas, Seval Beykan, Hakim Bouterfa, Jens Kaufmann, Andreas Bauman, Michael Lassmann, Jean Claude Reubi, Jean E.F. Rivier, Helmut R. Maecke, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 909-914; DOI: https://doi.org/10.2967/jnumed.117.199737

  2. Marcus, Carol S.

    1. How Should the FDA Review Diagnostic Radiopharmaceuticals?
      Carol S. Marcus
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 868-870; DOI: https://doi.org/10.2967/jnumed.117.200337

  3. Marek, Ken

    1. Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
      Michael D. Devous, Abhinay D. Joshi, Michael Navitsky, Sudeepti Southekal, Michael J. Pontecorvo, Haiqing Shen, Ming Lu, William R. Shankle, John P. Seibyl, Ken Marek and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 937-943; DOI: https://doi.org/10.2967/jnumed.117.200691

  4. McDevitt, Michael R.

    1. α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1
      Sophie Poty, Lynn C. Francesconi, Michael R. McDevitt, Michael J. Morris and Jason S. Lewis
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 878-884; DOI: https://doi.org/10.2967/jnumed.116.186338

  5. Mintun, Mark A.

    1. Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity
      Sudeepti Southekal, Michael D. Devous, Ian Kennedy, Michael Navitsky, Ming Lu, Abhinay D. Joshi, Michael J. Pontecorvo and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 944-951; DOI: https://doi.org/10.2967/jnumed.117.200006
    2. Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
      Michael D. Devous, Abhinay D. Joshi, Michael Navitsky, Sudeepti Southekal, Michael J. Pontecorvo, Haiqing Shen, Ming Lu, William R. Shankle, John P. Seibyl, Ken Marek and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 937-943; DOI: https://doi.org/10.2967/jnumed.117.200691

  6. Mitterhauser, Markus

    1. Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
      László Papp, Nina Pötsch, Marko Grahovac, Victor Schmidbauer, Adelheid Woehrer, Matthias Preusser, Markus Mitterhauser, Barbara Kiesel, Wolfgang Wadsak, Thomas Beyer, Marcus Hacker and Tatjana Traub-Weidinger
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 892-899; DOI: https://doi.org/10.2967/jnumed.117.202267

  7. Morris, Michael J.

    1. α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1
      Sophie Poty, Lynn C. Francesconi, Michael R. McDevitt, Michael J. Morris and Jason S. Lewis
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 878-884; DOI: https://doi.org/10.2967/jnumed.116.186338

N

  1. Narayanan, Deepa

    1. Proceedings of the NCI SBIR Workshop on Molecularly Targeted Radionuclide Therapy
      Christie A. Canaria, M. Lisa Yeom, Jacek Capala and Deepa Narayanan
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 13N-14N;

  2. Navitsky, Michael

    1. Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity
      Sudeepti Southekal, Michael D. Devous, Ian Kennedy, Michael Navitsky, Ming Lu, Abhinay D. Joshi, Michael J. Pontecorvo and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 944-951; DOI: https://doi.org/10.2967/jnumed.117.200006
    2. Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
      Michael D. Devous, Abhinay D. Joshi, Michael Navitsky, Sudeepti Southekal, Michael J. Pontecorvo, Haiqing Shen, Ming Lu, William R. Shankle, John P. Seibyl, Ken Marek and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 937-943; DOI: https://doi.org/10.2967/jnumed.117.200691

  3. Ni, Ruiqing

    1. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
      Ruiqing Ni, Bin Ji, Maiko Ono, Naruhiko Sahara, Ming-Rong Zhang, Ichio Aoki, Agneta Nordberg, Tetsuya Suhara and Makoto Higuchi
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 960-966; DOI: https://doi.org/10.2967/jnumed.117.201632

  4. Nicolas, Guillaume P.

    1. Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
      Guillaume P. Nicolas, Seval Beykan, Hakim Bouterfa, Jens Kaufmann, Andreas Bauman, Michael Lassmann, Jean Claude Reubi, Jean E.F. Rivier, Helmut R. Maecke, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 909-914; DOI: https://doi.org/10.2967/jnumed.117.199737
    2. Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
      Guillaume P. Nicolas, Nils Schreiter, Felix Kaul, John Uiters, Hakim Bouterfa, Jens Kaufmann, Tobias E. Erlanger, Richard Cathomas, Emanuel Christ, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 915-921; DOI: https://doi.org/10.2967/jnumed.117.199760

  5. Niu, Gang

    1. PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients
      Jingjing Zhang, Gang Niu, Xinrong Fan, Lixin Lang, Guozhu Hou, Libo Chen, Huanwen Wu, Zhaohui Zhu, Fang Li and Xiaoyuan Chen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 922-928; DOI: https://doi.org/10.2967/jnumed.117.198929

  6. Nordberg, Agneta

    1. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
      Ruiqing Ni, Bin Ji, Maiko Ono, Naruhiko Sahara, Ming-Rong Zhang, Ichio Aoki, Agneta Nordberg, Tetsuya Suhara and Makoto Higuchi
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 960-966; DOI: https://doi.org/10.2967/jnumed.117.201632

  7. Nuijen, Bastiaan

    1. Molecular Imaging of ABCB1 and ABCG2 Inhibition at the Human Blood–Brain Barrier Using Elacridar and 11C-Erlotinib PET
      Remy B. Verheijen, Maqsood Yaqub, Emilia Sawicki, Olaf van Tellingen, Adriaan A. Lammertsma, Bastiaan Nuijen, Jan H.M. Schellens, Jos H. Beijnen, Alwin D.R. Huitema, N. Harry Hendrikse and Neeltje Steeghs
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 973-979; DOI: https://doi.org/10.2967/jnumed.117.195800

O

  1. O’Donoghue, Joseph A.

    1. First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
      Gary A. Ulaner, Serge K. Lyashchenko, Christopher Riedl, Shutian Ruan, Pat B. Zanzonico, Diana Lake, Komal Jhaveri, Brian Zeglis, Jason S. Lewis and Joseph A. O’Donoghue
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 900-906; DOI: https://doi.org/10.2967/jnumed.117.202010

  2. Olin, Anders

    1. Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
      Anders Olin, Claes N. Ladefoged, Natasha H. Langer, Sune H. Keller, Johan Löfgren, Adam E. Hansen, Andreas Kjær, Seppo W. Langer, Barbara M. Fischer and Flemming L. Andersen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 999-1004; DOI: https://doi.org/10.2967/jnumed.117.198853

  3. Ono, Maiko

    1. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
      Ruiqing Ni, Bin Ji, Maiko Ono, Naruhiko Sahara, Ming-Rong Zhang, Ichio Aoki, Agneta Nordberg, Tetsuya Suhara and Makoto Higuchi
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 960-966; DOI: https://doi.org/10.2967/jnumed.117.201632

  4. Orlova, Anna

    1. Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology
      Ahmet Krasniqi, Matthias D’Huyvetter, Nick Devoogdt, Fredrik Y. Frejd, Jens Sörensen, Anna Orlova, Marleen Keyaerts and Vladimir Tolmachev
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 885-891; DOI: https://doi.org/10.2967/jnumed.117.199901

P

  1. Papp, László

    1. Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
      László Papp, Nina Pötsch, Marko Grahovac, Victor Schmidbauer, Adelheid Woehrer, Matthias Preusser, Markus Mitterhauser, Barbara Kiesel, Wolfgang Wadsak, Thomas Beyer, Marcus Hacker and Tatjana Traub-Weidinger
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 892-899; DOI: https://doi.org/10.2967/jnumed.117.202267

  2. Patel, Brijesh

    1. Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging
      Eric Berg, Xuezhu Zhang, Julien Bec, Martin S. Judenhofer, Brijesh Patel, Qiyu Peng, Maciej Kapusta, Matthias Schmand, Michael E. Casey, Alice F. Tarantal, Jinyi Qi, Ramsey D. Badawi and Simon R. Cherry
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 993-998; DOI: https://doi.org/10.2967/jnumed.117.200519

  3. Peng, Qiyu

    1. Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging
      Eric Berg, Xuezhu Zhang, Julien Bec, Martin S. Judenhofer, Brijesh Patel, Qiyu Peng, Maciej Kapusta, Matthias Schmand, Michael E. Casey, Alice F. Tarantal, Jinyi Qi, Ramsey D. Badawi and Simon R. Cherry
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 993-998; DOI: https://doi.org/10.2967/jnumed.117.200519

  4. Pomper, Martin G.

    1. Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
      Roberto A. Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, Susan C. Harvey, Mehrbod S. Javadi, Lilja B. Solnes, Ana P. Kiess, Mohamad E. Allaf, Martin G. Pomper, Michael A. Gorin and Steven P. Rowe
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 871-877; DOI: https://doi.org/10.2967/jnumed.117.203570

  5. Pontecorvo, Michael J.

    1. Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity
      Sudeepti Southekal, Michael D. Devous, Ian Kennedy, Michael Navitsky, Ming Lu, Abhinay D. Joshi, Michael J. Pontecorvo and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 944-951; DOI: https://doi.org/10.2967/jnumed.117.200006
    2. Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
      Michael D. Devous, Abhinay D. Joshi, Michael Navitsky, Sudeepti Southekal, Michael J. Pontecorvo, Haiqing Shen, Ming Lu, William R. Shankle, John P. Seibyl, Ken Marek and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 937-943; DOI: https://doi.org/10.2967/jnumed.117.200691

  6. Pötsch, Nina

    1. Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
      László Papp, Nina Pötsch, Marko Grahovac, Victor Schmidbauer, Adelheid Woehrer, Matthias Preusser, Markus Mitterhauser, Barbara Kiesel, Wolfgang Wadsak, Thomas Beyer, Marcus Hacker and Tatjana Traub-Weidinger
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 892-899; DOI: https://doi.org/10.2967/jnumed.117.202267

  7. Poty, Sophie

    1. α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1
      Sophie Poty, Lynn C. Francesconi, Michael R. McDevitt, Michael J. Morris and Jason S. Lewis
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 878-884; DOI: https://doi.org/10.2967/jnumed.116.186338

  8. Preusser, Matthias

    1. Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
      László Papp, Nina Pötsch, Marko Grahovac, Victor Schmidbauer, Adelheid Woehrer, Matthias Preusser, Markus Mitterhauser, Barbara Kiesel, Wolfgang Wadsak, Thomas Beyer, Marcus Hacker and Tatjana Traub-Weidinger
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 892-899; DOI: https://doi.org/10.2967/jnumed.117.202267

Q

  1. Qi, Jinyi

    1. Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging
      Eric Berg, Xuezhu Zhang, Julien Bec, Martin S. Judenhofer, Brijesh Patel, Qiyu Peng, Maciej Kapusta, Matthias Schmand, Michael E. Casey, Alice F. Tarantal, Jinyi Qi, Ramsey D. Badawi and Simon R. Cherry
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 993-998; DOI: https://doi.org/10.2967/jnumed.117.200519

R

  1. Reubi, Jean Claude

    1. Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
      Guillaume P. Nicolas, Seval Beykan, Hakim Bouterfa, Jens Kaufmann, Andreas Bauman, Michael Lassmann, Jean Claude Reubi, Jean E.F. Rivier, Helmut R. Maecke, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 909-914; DOI: https://doi.org/10.2967/jnumed.117.199737

  2. Riedl, Christopher

    1. First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
      Gary A. Ulaner, Serge K. Lyashchenko, Christopher Riedl, Shutian Ruan, Pat B. Zanzonico, Diana Lake, Komal Jhaveri, Brian Zeglis, Jason S. Lewis and Joseph A. O’Donoghue
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 900-906; DOI: https://doi.org/10.2967/jnumed.117.202010

  3. Rivier, Jean E.F.

    1. Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
      Guillaume P. Nicolas, Seval Beykan, Hakim Bouterfa, Jens Kaufmann, Andreas Bauman, Michael Lassmann, Jean Claude Reubi, Jean E.F. Rivier, Helmut R. Maecke, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 909-914; DOI: https://doi.org/10.2967/jnumed.117.199737

  4. Rowe, Steven P.

    1. Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
      Roberto A. Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, Susan C. Harvey, Mehrbod S. Javadi, Lilja B. Solnes, Ana P. Kiess, Mohamad E. Allaf, Martin G. Pomper, Michael A. Gorin and Steven P. Rowe
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 871-877; DOI: https://doi.org/10.2967/jnumed.117.203570

  5. Rozengurt, Nora

    1. Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis
      Amanda C. Freise, Kirstin A. Zettlitz, Felix B. Salazar, Richard Tavaré, Wen-Ting K. Tsai, Arion F. Chatziioannou, Nora Rozengurt, Jonathan Braun and Anna M. Wu
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 980-985; DOI: https://doi.org/10.2967/jnumed.117.199075

  6. Ruan, Shutian

    1. First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
      Gary A. Ulaner, Serge K. Lyashchenko, Christopher Riedl, Shutian Ruan, Pat B. Zanzonico, Diana Lake, Komal Jhaveri, Brian Zeglis, Jason S. Lewis and Joseph A. O’Donoghue
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 900-906; DOI: https://doi.org/10.2967/jnumed.117.202010

S

  1. Sahara, Naruhiko

    1. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
      Ruiqing Ni, Bin Ji, Maiko Ono, Naruhiko Sahara, Ming-Rong Zhang, Ichio Aoki, Agneta Nordberg, Tetsuya Suhara and Makoto Higuchi
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 960-966; DOI: https://doi.org/10.2967/jnumed.117.201632

  2. Salas Fragomeni, Roberto A.

    1. Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
      Roberto A. Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, Susan C. Harvey, Mehrbod S. Javadi, Lilja B. Solnes, Ana P. Kiess, Mohamad E. Allaf, Martin G. Pomper, Michael A. Gorin and Steven P. Rowe
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 871-877; DOI: https://doi.org/10.2967/jnumed.117.203570

  3. Salazar, Felix B.

    1. Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis
      Amanda C. Freise, Kirstin A. Zettlitz, Felix B. Salazar, Richard Tavaré, Wen-Ting K. Tsai, Arion F. Chatziioannou, Nora Rozengurt, Jonathan Braun and Anna M. Wu
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 980-985; DOI: https://doi.org/10.2967/jnumed.117.199075

  4. Sawicki, Emilia

    1. Molecular Imaging of ABCB1 and ABCG2 Inhibition at the Human Blood–Brain Barrier Using Elacridar and 11C-Erlotinib PET
      Remy B. Verheijen, Maqsood Yaqub, Emilia Sawicki, Olaf van Tellingen, Adriaan A. Lammertsma, Bastiaan Nuijen, Jan H.M. Schellens, Jos H. Beijnen, Alwin D.R. Huitema, N. Harry Hendrikse and Neeltje Steeghs
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 973-979; DOI: https://doi.org/10.2967/jnumed.117.195800

  5. Schellens, Jan H.M.

    1. Molecular Imaging of ABCB1 and ABCG2 Inhibition at the Human Blood–Brain Barrier Using Elacridar and 11C-Erlotinib PET
      Remy B. Verheijen, Maqsood Yaqub, Emilia Sawicki, Olaf van Tellingen, Adriaan A. Lammertsma, Bastiaan Nuijen, Jan H.M. Schellens, Jos H. Beijnen, Alwin D.R. Huitema, N. Harry Hendrikse and Neeltje Steeghs
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 973-979; DOI: https://doi.org/10.2967/jnumed.117.195800

  6. Schmand, Matthias

    1. Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging
      Eric Berg, Xuezhu Zhang, Julien Bec, Martin S. Judenhofer, Brijesh Patel, Qiyu Peng, Maciej Kapusta, Matthias Schmand, Michael E. Casey, Alice F. Tarantal, Jinyi Qi, Ramsey D. Badawi and Simon R. Cherry
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 993-998; DOI: https://doi.org/10.2967/jnumed.117.200519

  7. Schmidbauer, Victor

    1. Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
      László Papp, Nina Pötsch, Marko Grahovac, Victor Schmidbauer, Adelheid Woehrer, Matthias Preusser, Markus Mitterhauser, Barbara Kiesel, Wolfgang Wadsak, Thomas Beyer, Marcus Hacker and Tatjana Traub-Weidinger
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 892-899; DOI: https://doi.org/10.2967/jnumed.117.202267

  8. Schreiter, Nils

    1. Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
      Guillaume P. Nicolas, Nils Schreiter, Felix Kaul, John Uiters, Hakim Bouterfa, Jens Kaufmann, Tobias E. Erlanger, Richard Cathomas, Emanuel Christ, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 915-921; DOI: https://doi.org/10.2967/jnumed.117.199760

  9. Schwarz, Sally W.

    1. Perspective on How the FDA Should Review Diagnostic Radiopharmaceuticals
      Sally W. Schwarz and Bonnie Clarke
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 865-867; DOI: https://doi.org/10.2967/jnumed.117.204446

  10. Segall, George M.

    1. ABNM Support for Research During Training
      George M. Segall
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 16N;

  11. Seibyl, John P.

    1. Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
      Michael D. Devous, Abhinay D. Joshi, Michael Navitsky, Sudeepti Southekal, Michael J. Pontecorvo, Haiqing Shen, Ming Lu, William R. Shankle, John P. Seibyl, Ken Marek and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 937-943; DOI: https://doi.org/10.2967/jnumed.117.200691

  12. Shankle, William R.

    1. Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
      Michael D. Devous, Abhinay D. Joshi, Michael Navitsky, Sudeepti Southekal, Michael J. Pontecorvo, Haiqing Shen, Ming Lu, William R. Shankle, John P. Seibyl, Ken Marek and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 937-943; DOI: https://doi.org/10.2967/jnumed.117.200691

  13. Sheikhbahaei, Sara

    1. Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
      Roberto A. Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, Susan C. Harvey, Mehrbod S. Javadi, Lilja B. Solnes, Ana P. Kiess, Mohamad E. Allaf, Martin G. Pomper, Michael A. Gorin and Steven P. Rowe
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 871-877; DOI: https://doi.org/10.2967/jnumed.117.203570

  14. Shen, Haiqing

    1. Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
      Michael D. Devous, Abhinay D. Joshi, Michael Navitsky, Sudeepti Southekal, Michael J. Pontecorvo, Haiqing Shen, Ming Lu, William R. Shankle, John P. Seibyl, Ken Marek and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 937-943; DOI: https://doi.org/10.2967/jnumed.117.200691

  15. Smuck, Matthew W.

    1. 18F-FDG PET/MRI in Chronic Sciatica: Early Results Revealing Spinal and Nonspinal Abnormalities
      Peter W. Cipriano, Daehyun Yoon, Harsh Gandhi, Dawn Holley, Dushyant Thakur, Brian A. Hargreaves, David J. Kennedy, Matthew W. Smuck, Ivan Cheng and Sandip Biswal
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 967-972; DOI: https://doi.org/10.2967/jnumed.117.198259

  16. Solnes, Lilja B.

    1. Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
      Roberto A. Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, Susan C. Harvey, Mehrbod S. Javadi, Lilja B. Solnes, Ana P. Kiess, Mohamad E. Allaf, Martin G. Pomper, Michael A. Gorin and Steven P. Rowe
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 871-877; DOI: https://doi.org/10.2967/jnumed.117.203570

  17. Sörensen, Jens

    1. Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology
      Ahmet Krasniqi, Matthias D’Huyvetter, Nick Devoogdt, Fredrik Y. Frejd, Jens Sörensen, Anna Orlova, Marleen Keyaerts and Vladimir Tolmachev
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 885-891; DOI: https://doi.org/10.2967/jnumed.117.199901

  18. Southekal, Sudeepti

    1. Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity
      Sudeepti Southekal, Michael D. Devous, Ian Kennedy, Michael Navitsky, Ming Lu, Abhinay D. Joshi, Michael J. Pontecorvo and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 944-951; DOI: https://doi.org/10.2967/jnumed.117.200006
    2. Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
      Michael D. Devous, Abhinay D. Joshi, Michael Navitsky, Sudeepti Southekal, Michael J. Pontecorvo, Haiqing Shen, Ming Lu, William R. Shankle, John P. Seibyl, Ken Marek and Mark A. Mintun
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 937-943; DOI: https://doi.org/10.2967/jnumed.117.200691

  19. Spa, Silvia J.

    1. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer
      Tessa Buckle, Danny M. van Willigen, Silvia J. Spa, Albertus W. Hensbergen, Steffen van der Wal, Clarize M. de Korne, Mick M. Welling, Henk G. van der Poel, James C.H. Hardwick and Fijs W.B. van Leeuwen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 986-992; DOI: https://doi.org/10.2967/jnumed.117.205575

  20. Stabin, Michael G.

    1. New-Generation Fetal Dose Estimates for Radiopharmaceuticals
      Michael G. Stabin
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 1005-1006; DOI: https://doi.org/10.2967/jnumed.117.204214

  21. Steeghs, Neeltje

    1. Molecular Imaging of ABCB1 and ABCG2 Inhibition at the Human Blood–Brain Barrier Using Elacridar and 11C-Erlotinib PET
      Remy B. Verheijen, Maqsood Yaqub, Emilia Sawicki, Olaf van Tellingen, Adriaan A. Lammertsma, Bastiaan Nuijen, Jan H.M. Schellens, Jos H. Beijnen, Alwin D.R. Huitema, N. Harry Hendrikse and Neeltje Steeghs
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 973-979; DOI: https://doi.org/10.2967/jnumed.117.195800

  22. Suhara, Tetsuya

    1. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
      Ruiqing Ni, Bin Ji, Maiko Ono, Naruhiko Sahara, Ming-Rong Zhang, Ichio Aoki, Agneta Nordberg, Tetsuya Suhara and Makoto Higuchi
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 960-966; DOI: https://doi.org/10.2967/jnumed.117.201632

T

  1. Tarantal, Alice F.

    1. Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging
      Eric Berg, Xuezhu Zhang, Julien Bec, Martin S. Judenhofer, Brijesh Patel, Qiyu Peng, Maciej Kapusta, Matthias Schmand, Michael E. Casey, Alice F. Tarantal, Jinyi Qi, Ramsey D. Badawi and Simon R. Cherry
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 993-998; DOI: https://doi.org/10.2967/jnumed.117.200519

  2. Tauber, Robert

    1. The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177Lu-Labeled PSMA Peptides
      Nusrat J. Begum, Anne Thieme, Nina Eberhardt, Robert Tauber, Calogero D’Alessandria, Ambros J. Beer, Gerhard Glatting, Matthias Eiber and Peter Kletting
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 929-933; DOI: https://doi.org/10.2967/jnumed.117.203505

  3. Tavaré, Richard

    1. Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis
      Amanda C. Freise, Kirstin A. Zettlitz, Felix B. Salazar, Richard Tavaré, Wen-Ting K. Tsai, Arion F. Chatziioannou, Nora Rozengurt, Jonathan Braun and Anna M. Wu
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 980-985; DOI: https://doi.org/10.2967/jnumed.117.199075

  4. Thakur, Dushyant

    1. 18F-FDG PET/MRI in Chronic Sciatica: Early Results Revealing Spinal and Nonspinal Abnormalities
      Peter W. Cipriano, Daehyun Yoon, Harsh Gandhi, Dawn Holley, Dushyant Thakur, Brian A. Hargreaves, David J. Kennedy, Matthew W. Smuck, Ivan Cheng and Sandip Biswal
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 967-972; DOI: https://doi.org/10.2967/jnumed.117.198259

  5. Thieme, Anne

    1. The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177Lu-Labeled PSMA Peptides
      Nusrat J. Begum, Anne Thieme, Nina Eberhardt, Robert Tauber, Calogero D’Alessandria, Ambros J. Beer, Gerhard Glatting, Matthias Eiber and Peter Kletting
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 929-933; DOI: https://doi.org/10.2967/jnumed.117.203505

  6. Tolmachev, Vladimir

    1. Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology
      Ahmet Krasniqi, Matthias D’Huyvetter, Nick Devoogdt, Fredrik Y. Frejd, Jens Sörensen, Anna Orlova, Marleen Keyaerts and Vladimir Tolmachev
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 885-891; DOI: https://doi.org/10.2967/jnumed.117.199901

  7. Traub-Weidinger, Tatjana

    1. Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
      László Papp, Nina Pötsch, Marko Grahovac, Victor Schmidbauer, Adelheid Woehrer, Matthias Preusser, Markus Mitterhauser, Barbara Kiesel, Wolfgang Wadsak, Thomas Beyer, Marcus Hacker and Tatjana Traub-Weidinger
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 892-899; DOI: https://doi.org/10.2967/jnumed.117.202267

  8. Tsai, Wen-Ting K.

    1. Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis
      Amanda C. Freise, Kirstin A. Zettlitz, Felix B. Salazar, Richard Tavaré, Wen-Ting K. Tsai, Arion F. Chatziioannou, Nora Rozengurt, Jonathan Braun and Anna M. Wu
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 980-985; DOI: https://doi.org/10.2967/jnumed.117.199075

U

  1. Uiters, John

    1. Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
      Guillaume P. Nicolas, Nils Schreiter, Felix Kaul, John Uiters, Hakim Bouterfa, Jens Kaufmann, Tobias E. Erlanger, Richard Cathomas, Emanuel Christ, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 915-921; DOI: https://doi.org/10.2967/jnumed.117.199760

  2. Ulaner, Gary A.

    1. First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
      Gary A. Ulaner, Serge K. Lyashchenko, Christopher Riedl, Shutian Ruan, Pat B. Zanzonico, Diana Lake, Komal Jhaveri, Brian Zeglis, Jason S. Lewis and Joseph A. O’Donoghue
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 900-906; DOI: https://doi.org/10.2967/jnumed.117.202010

V

  1. van der Poel, Henk G.

    1. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer
      Tessa Buckle, Danny M. van Willigen, Silvia J. Spa, Albertus W. Hensbergen, Steffen van der Wal, Clarize M. de Korne, Mick M. Welling, Henk G. van der Poel, James C.H. Hardwick and Fijs W.B. van Leeuwen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 986-992; DOI: https://doi.org/10.2967/jnumed.117.205575

  2. van der Wal, Steffen

    1. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer
      Tessa Buckle, Danny M. van Willigen, Silvia J. Spa, Albertus W. Hensbergen, Steffen van der Wal, Clarize M. de Korne, Mick M. Welling, Henk G. van der Poel, James C.H. Hardwick and Fijs W.B. van Leeuwen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 986-992; DOI: https://doi.org/10.2967/jnumed.117.205575

  3. Van Laere, Koen

    1. Glutamatergic Biomarkers for Cocaine Addiction: A Longitudinal Study Using MR Spectroscopy and mGluR5 PET in Self-Administering Rats
      Bart de Laat, Akila Weerasekera, Gil Leurquin-Sterk, Guy Bormans, Uwe Himmelreich, Cindy Casteels and Koen Van Laere
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 952-959; DOI: https://doi.org/10.2967/jnumed.117.202614

  4. van Leeuwen, Fijs W.B.

    1. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer
      Tessa Buckle, Danny M. van Willigen, Silvia J. Spa, Albertus W. Hensbergen, Steffen van der Wal, Clarize M. de Korne, Mick M. Welling, Henk G. van der Poel, James C.H. Hardwick and Fijs W.B. van Leeuwen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 986-992; DOI: https://doi.org/10.2967/jnumed.117.205575

  5. van Tellingen, Olaf

    1. Molecular Imaging of ABCB1 and ABCG2 Inhibition at the Human Blood–Brain Barrier Using Elacridar and 11C-Erlotinib PET
      Remy B. Verheijen, Maqsood Yaqub, Emilia Sawicki, Olaf van Tellingen, Adriaan A. Lammertsma, Bastiaan Nuijen, Jan H.M. Schellens, Jos H. Beijnen, Alwin D.R. Huitema, N. Harry Hendrikse and Neeltje Steeghs
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 973-979; DOI: https://doi.org/10.2967/jnumed.117.195800

  6. van Willigen, Danny M.

    1. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer
      Tessa Buckle, Danny M. van Willigen, Silvia J. Spa, Albertus W. Hensbergen, Steffen van der Wal, Clarize M. de Korne, Mick M. Welling, Henk G. van der Poel, James C.H. Hardwick and Fijs W.B. van Leeuwen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 986-992; DOI: https://doi.org/10.2967/jnumed.117.205575

  7. Verheijen, Remy B.

    1. Molecular Imaging of ABCB1 and ABCG2 Inhibition at the Human Blood–Brain Barrier Using Elacridar and 11C-Erlotinib PET
      Remy B. Verheijen, Maqsood Yaqub, Emilia Sawicki, Olaf van Tellingen, Adriaan A. Lammertsma, Bastiaan Nuijen, Jan H.M. Schellens, Jos H. Beijnen, Alwin D.R. Huitema, N. Harry Hendrikse and Neeltje Steeghs
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 973-979; DOI: https://doi.org/10.2967/jnumed.117.195800

W

  1. Wadsak, Wolfgang

    1. Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
      László Papp, Nina Pötsch, Marko Grahovac, Victor Schmidbauer, Adelheid Woehrer, Matthias Preusser, Markus Mitterhauser, Barbara Kiesel, Wolfgang Wadsak, Thomas Beyer, Marcus Hacker and Tatjana Traub-Weidinger
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 892-899; DOI: https://doi.org/10.2967/jnumed.117.202267

  2. Weber, Wolfgang A.

    1. Somatostatin Receptor Imaging of Neuroendocrine Tumors: From Agonists to Antagonists
      Lisa Bodei and Wolfgang A. Weber
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 907-908; DOI: https://doi.org/10.2967/jnumed.117.205161

  3. Weerasekera, Akila

    1. Glutamatergic Biomarkers for Cocaine Addiction: A Longitudinal Study Using MR Spectroscopy and mGluR5 PET in Self-Administering Rats
      Bart de Laat, Akila Weerasekera, Gil Leurquin-Sterk, Guy Bormans, Uwe Himmelreich, Cindy Casteels and Koen Van Laere
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 952-959; DOI: https://doi.org/10.2967/jnumed.117.202614

  4. Welling, Mick M.

    1. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer
      Tessa Buckle, Danny M. van Willigen, Silvia J. Spa, Albertus W. Hensbergen, Steffen van der Wal, Clarize M. de Korne, Mick M. Welling, Henk G. van der Poel, James C.H. Hardwick and Fijs W.B. van Leeuwen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 986-992; DOI: https://doi.org/10.2967/jnumed.117.205575

  5. Wild, Damian

    1. Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
      Guillaume P. Nicolas, Seval Beykan, Hakim Bouterfa, Jens Kaufmann, Andreas Bauman, Michael Lassmann, Jean Claude Reubi, Jean E.F. Rivier, Helmut R. Maecke, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 909-914; DOI: https://doi.org/10.2967/jnumed.117.199737
    2. Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
      Guillaume P. Nicolas, Nils Schreiter, Felix Kaul, John Uiters, Hakim Bouterfa, Jens Kaufmann, Tobias E. Erlanger, Richard Cathomas, Emanuel Christ, Melpomeni Fani and Damian Wild
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 915-921; DOI: https://doi.org/10.2967/jnumed.117.199760

  6. Woehrer, Adelheid

    1. Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
      László Papp, Nina Pötsch, Marko Grahovac, Victor Schmidbauer, Adelheid Woehrer, Matthias Preusser, Markus Mitterhauser, Barbara Kiesel, Wolfgang Wadsak, Thomas Beyer, Marcus Hacker and Tatjana Traub-Weidinger
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 892-899; DOI: https://doi.org/10.2967/jnumed.117.202267

  7. Wu, Anna M.

    1. Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis
      Amanda C. Freise, Kirstin A. Zettlitz, Felix B. Salazar, Richard Tavaré, Wen-Ting K. Tsai, Arion F. Chatziioannou, Nora Rozengurt, Jonathan Braun and Anna M. Wu
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 980-985; DOI: https://doi.org/10.2967/jnumed.117.199075

  8. Wu, Huanwen

    1. PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients
      Jingjing Zhang, Gang Niu, Xinrong Fan, Lixin Lang, Guozhu Hou, Libo Chen, Huanwen Wu, Zhaohui Zhu, Fang Li and Xiaoyuan Chen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 922-928; DOI: https://doi.org/10.2967/jnumed.117.198929

Y

  1. Yaqub, Maqsood

    1. Molecular Imaging of ABCB1 and ABCG2 Inhibition at the Human Blood–Brain Barrier Using Elacridar and 11C-Erlotinib PET
      Remy B. Verheijen, Maqsood Yaqub, Emilia Sawicki, Olaf van Tellingen, Adriaan A. Lammertsma, Bastiaan Nuijen, Jan H.M. Schellens, Jos H. Beijnen, Alwin D.R. Huitema, N. Harry Hendrikse and Neeltje Steeghs
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 973-979; DOI: https://doi.org/10.2967/jnumed.117.195800

  2. Yoon, Daehyun

    1. 18F-FDG PET/MRI in Chronic Sciatica: Early Results Revealing Spinal and Nonspinal Abnormalities
      Peter W. Cipriano, Daehyun Yoon, Harsh Gandhi, Dawn Holley, Dushyant Thakur, Brian A. Hargreaves, David J. Kennedy, Matthew W. Smuck, Ivan Cheng and Sandip Biswal
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 967-972; DOI: https://doi.org/10.2967/jnumed.117.198259

Z

  1. Zanzonico, Pat B.

    1. First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
      Gary A. Ulaner, Serge K. Lyashchenko, Christopher Riedl, Shutian Ruan, Pat B. Zanzonico, Diana Lake, Komal Jhaveri, Brian Zeglis, Jason S. Lewis and Joseph A. O’Donoghue
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 900-906; DOI: https://doi.org/10.2967/jnumed.117.202010

  2. Zeglis, Brian

    1. First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
      Gary A. Ulaner, Serge K. Lyashchenko, Christopher Riedl, Shutian Ruan, Pat B. Zanzonico, Diana Lake, Komal Jhaveri, Brian Zeglis, Jason S. Lewis and Joseph A. O’Donoghue
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 900-906; DOI: https://doi.org/10.2967/jnumed.117.202010

  3. Zettlitz, Kirstin A.

    1. Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis
      Amanda C. Freise, Kirstin A. Zettlitz, Felix B. Salazar, Richard Tavaré, Wen-Ting K. Tsai, Arion F. Chatziioannou, Nora Rozengurt, Jonathan Braun and Anna M. Wu
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 980-985; DOI: https://doi.org/10.2967/jnumed.117.199075

  4. Zhang, Jingjing

    1. PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients
      Jingjing Zhang, Gang Niu, Xinrong Fan, Lixin Lang, Guozhu Hou, Libo Chen, Huanwen Wu, Zhaohui Zhu, Fang Li and Xiaoyuan Chen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 922-928; DOI: https://doi.org/10.2967/jnumed.117.198929

  5. Zhang, Ming-Rong

    1. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
      Ruiqing Ni, Bin Ji, Maiko Ono, Naruhiko Sahara, Ming-Rong Zhang, Ichio Aoki, Agneta Nordberg, Tetsuya Suhara and Makoto Higuchi
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 960-966; DOI: https://doi.org/10.2967/jnumed.117.201632

  6. Zhang, Xuezhu

    1. Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging
      Eric Berg, Xuezhu Zhang, Julien Bec, Martin S. Judenhofer, Brijesh Patel, Qiyu Peng, Maciej Kapusta, Matthias Schmand, Michael E. Casey, Alice F. Tarantal, Jinyi Qi, Ramsey D. Badawi and Simon R. Cherry
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 993-998; DOI: https://doi.org/10.2967/jnumed.117.200519

  7. Zhu, Zhaohui

    1. PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients
      Jingjing Zhang, Gang Niu, Xinrong Fan, Lixin Lang, Guozhu Hou, Libo Chen, Huanwen Wu, Zhaohui Zhu, Fang Li and Xiaoyuan Chen
      Journal of Nuclear Medicine June 1, 2018, 59 (6) 922-928; DOI: https://doi.org/10.2967/jnumed.117.198929
Back to top

In this issue